B2i Digital, Inc. has announced the Life Sciences Virtual Investor Forum, a two-day event co-hosted by Zacks Small-Cap Research, scheduled for June 24 and 25, 2026. The forum will feature presentations from more than 20 public companies spanning biotechnology, diagnostics, medical devices, and digital health. Investors will have the opportunity to engage with management teams through live presentations, real-time Q&A, and one-on-one meetings.
The event is designed to provide efficient access to companies developing therapies and technologies in areas such as rare diseases, oncology, molecular diagnostics, and AI-powered digital health. B2i Digital serves as the Official Marketing Partner, leveraging its distribution network to reach over 1.7 million retail and institutional market participants. Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, brings independent analyst coverage to the forum.
Presenting companies on Day One, June 24, include Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings Inc., Jaguar Health, Inc., Reviva Pharmaceuticals Holdings, Inc., and 4DMedical Ltd. Day Two, June 25, features Prostatype Genomics AB, Abingdon Health plc, Innovotech, Inc., Lakewood-Amedex Biotherapeutics Inc., Nasus Pharma Ltd., Kelyniam Global, Inc., IMUNON, Inc., Promino Nutritional Sciences Inc., Envoy Medical Inc., Coiled Therapeutics plc, Aspire Biopharma Holdings Inc., Rocket Doctor AI Inc., Phio Pharmaceuticals Corp., aTyr Pharma, Inc., and NuFarm Ltd.
Each company will have 30 minutes for a live presentation followed by Q&A. One-on-one meeting requests can be made through the Axle Access platform. Replays will be available on B2i Digital and OTC Markets YouTube channels. Registration and company profiles are accessible via the Virtual Investor Conferences website.
David Shapiro, CEO of B2i Digital, emphasized the value of combining direct access to management with independent research from Zacks, noting that the forum allows investors to meet companies across multiple life sciences sectors and form their own conclusions. The event is part of the broader Virtual Investor Conferences series, which features public companies from exchanges worldwide including NYSE, Nasdaq, TSX, and OTC Markets.
B2i Digital's role as marketing partner extends beyond the event, with a distribution engine that amplifies presentations before, during, and after the conference. The company has served as marketing partner for over 115 investor conferences, utilizing its proprietary network of more than 1.7 million market participants.
The Life Sciences Virtual Investor Forum underscores the growing trend of virtual events that provide efficient, direct engagement between investors and company management, particularly in the life sciences sector where specialized knowledge is critical.
